The Liotta Research Group (LRG) is an Emory-based medicinal chemistry and drug discovery research group, led by Dr. Dennis Liotta. Our focus is the discovery and development of novel therapeutic agents. The drugs, generated by the LRG over several decades, include therapies for HIV, hepatitis B (HBV), cancer and neurological disorders, to name a few. In addition to our ongoing programs in antivirals and prodrug platform technologies, our current efforts include designing and developing novel non-opioid analgesics, anti-anxiolytics, NMDA receptor modulators, chemotherapeutics and immuno-oncology agents.
We are seeking highly motivated Postdoctoral Fellows for our medicinal and synthetic chemistry group. They are expected to perform duties with a high degree of independence, initiative and judgment. The project(s) will focus on the design and synthesis, followed by in vitro and in vivo profiling, of novel therapeutic agents and then the optimization of synthetic processes to prepare such compounds to meet key development objectives and milestones. Furthermore, interested individuals must also be motivated to prepare key research results and findings for peer-review publications, oral presentations and patent applications. A successful applicant will join our multidisciplinary research group working on fully integrated activities for the discovery and development of novel therapeutic agents.
A Ph.D. in synthetic organic chemistry, medicinal chemistry or related fields is required. The primary criteria for selection of an appropriate candidate include a strong background and demonstrated proficiency in multi-step organic synthesis of complex molecules, a thorough grasp and command of modern and classic organic transformations and mechanisms and a strong interest and background in the drug discovery process.
